Nifty
:
24266.55
Sensex
:
79735.40
-35.60 (-0.15%)
-314.27 (-0.39%)
Nifty
Sensex
:
:
24266.55
79735.40
-35.60 (-0.15%)
-314.27 (-0.39%)

Bharat Parenterals Ltd.

Pharmaceuticals & Drugs

Rating :
53/99

BSE: 541096 | NSE: Not Listed

NSE BSE
1518.75
04-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  1550.00
  •  1550.00
  •  1500.10
  •  1530.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  44
  •  8.77
  •  1824.70
  •  374.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 990.90
  • 68.26
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,136.39
  • 0.07%
  • 3.38

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 73.27%
  • 8.43%
  • 13.61%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 4.69%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.91
  • 2.44
  • 6.67

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.31
  • -3.43
  • -3.61

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.75
  • -9.68
  • -11.66

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 10.20
  • 11.99

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 1.59
  • 1.70

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 7.95
  • 10.32

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Net Sales
67.82
50.97
33.06%
59.82
59.02
1.36%
59.80
81.90
-26.98%
69.91
26.09
167.96%
Expenses
66.82
44.75
49.32%
53.21
56.37
-5.61%
55.48
72.71
-23.70%
59.46
24.28
144.89%
EBITDA
1.00
6.22
-83.92%
6.61
2.65
149.43%
4.32
9.19
-52.99%
10.45
1.81
477.35%
EBIDTM
1.47%
12.20%
11.05%
4.49%
7.22%
11.22%
14.95%
6.94%
Other Income
2.64
0.31
751.61%
1.26
3.48
-63.79%
2.60
6.41
-59.44%
2.10
1.54
36.36%
Interest
1.13
0.80
41.25%
0.58
0.79
-26.58%
0.63
0.34
85.29%
0.89
0.25
256.00%
Depreciation
3.87
1.44
168.75%
1.82
1.44
26.39%
1.75
1.46
19.86%
1.58
1.54
2.60%
PBT
-1.36
4.29
-
5.47
3.90
40.26%
4.54
13.80
-67.10%
10.08
1.56
546.15%
Tax
1.20
2.02
-40.59%
1.83
1.43
27.97%
2.11
3.96
-46.72%
3.07
0.44
597.73%
PAT
-2.56
2.27
-
3.64
2.47
47.37%
2.43
9.84
-75.30%
7.01
1.12
525.89%
PATM
-3.77%
4.45%
6.08%
4.18%
4.06%
12.01%
10.03%
4.29%
EPS
-0.52
4.23
-
6.55
4.94
32.59%
6.05
17.18
-64.78%
13.03
2.05
535.61%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
-
257.36
217.98
212.01
204.64
228.18
219.54
136.58
111.44
124.11
Net Sales Growth
-
18.07%
2.82%
3.60%
-10.32%
3.94%
60.74%
22.56%
-10.21%
 
Cost Of Goods Sold
-
158.35
137.48
136.07
134.27
148.91
140.48
88.18
79.07
83.01
Gross Profit
-
99.01
80.50
75.95
70.38
79.26
79.06
48.39
32.37
41.10
GP Margin
-
38.47%
36.93%
35.82%
34.39%
34.74%
36.01%
35.43%
29.05%
33.12%
Total Expenditure
-
234.14
197.99
184.10
179.40
200.53
190.69
124.44
104.98
114.12
Power & Fuel Cost
-
4.69
3.75
3.21
3.10
3.19
2.70
2.62
1.79
2.06
% Of Sales
-
1.82%
1.72%
1.51%
1.51%
1.40%
1.23%
1.92%
1.61%
1.66%
Employee Cost
-
22.78
18.00
15.37
14.75
15.58
15.37
12.94
11.37
9.10
% Of Sales
-
8.85%
8.26%
7.25%
7.21%
6.83%
7.00%
9.47%
10.20%
7.33%
Manufacturing Exp.
-
13.15
11.16
8.43
7.35
8.60
9.12
5.01
4.07
3.78
% Of Sales
-
5.11%
5.12%
3.98%
3.59%
3.77%
4.15%
3.67%
3.65%
3.05%
General & Admin Exp.
-
8.40
6.21
3.09
2.53
2.88
3.47
1.91
1.46
4.54
% Of Sales
-
3.26%
2.85%
1.46%
1.24%
1.26%
1.58%
1.40%
1.31%
3.66%
Selling & Distn. Exp.
-
17.73
16.34
7.72
7.30
12.04
13.62
9.50
4.47
10.22
% Of Sales
-
6.89%
7.50%
3.64%
3.57%
5.28%
6.20%
6.96%
4.01%
8.23%
Miscellaneous Exp.
-
9.03
5.06
10.21
10.10
9.34
5.93
4.27
2.74
1.42
% Of Sales
-
3.51%
2.32%
4.82%
4.94%
4.09%
2.70%
3.13%
2.46%
1.14%
EBITDA
-
23.22
19.99
27.91
25.24
27.65
28.85
12.14
6.46
9.99
EBITDA Margin
-
9.02%
9.17%
13.16%
12.33%
12.12%
13.14%
8.89%
5.80%
8.05%
Other Income
-
8.59
12.04
7.93
8.68
11.90
12.74
7.17
7.71
5.05
Interest
-
4.07
2.60
1.31
0.77
0.86
0.87
0.94
0.91
1.49
Depreciation
-
9.02
5.88
6.66
6.03
5.88
6.13
5.57
5.79
4.20
PBT
-
18.72
23.55
27.88
27.12
32.80
34.59
12.79
7.48
9.35
Tax
-
8.21
7.83
7.06
6.81
8.65
13.35
3.68
0.59
2.89
Tax Rate
-
43.86%
33.25%
25.32%
25.11%
26.37%
38.59%
28.77%
7.89%
30.91%
PAT
-
14.51
16.39
21.05
20.39
24.14
21.25
9.12
6.89
6.45
PAT before Minority Interest
-
10.51
15.71
20.81
20.32
24.14
21.25
9.12
6.89
6.45
Minority Interest
-
4.00
0.68
0.24
0.07
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
5.64%
7.52%
9.93%
9.96%
10.58%
9.68%
6.68%
6.18%
5.20%
PAT Growth
-
-11.47%
-22.14%
3.24%
-15.53%
13.60%
133.00%
32.37%
6.82%
 
EPS
-
25.02
28.26
36.29
35.16
41.62
36.64
15.72
11.88
11.12

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
197.27
182.80
165.83
143.87
118.19
94.01
72.85
63.68
56.69
Share Capital
5.82
5.77
5.77
5.73
5.73
5.73
5.73
5.73
5.73
Total Reserves
191.45
176.49
160.05
137.71
112.46
88.28
67.12
57.95
50.96
Non-Current Liabilities
75.15
12.65
14.38
11.21
3.42
4.42
0.22
3.29
7.39
Secured Loans
73.16
10.92
9.75
8.59
0.71
0.97
2.34
3.67
6.57
Unsecured Loans
0.00
0.00
2.74
0.00
0.00
0.00
0.00
0.34
0.33
Long Term Provisions
2.10
1.33
0.94
0.64
0.51
0.09
0.08
0.00
0.00
Current Liabilities
190.38
119.80
41.53
43.63
65.88
60.51
56.88
42.79
56.18
Trade Payables
60.03
51.34
23.76
26.17
42.61
31.91
26.56
36.37
38.84
Other Current Liabilities
47.71
30.83
13.00
15.42
22.60
25.93
22.22
6.22
0.37
Short Term Borrowings
80.85
36.02
2.78
1.19
0.00
1.95
4.98
0.00
12.53
Short Term Provisions
1.80
1.60
1.99
0.84
0.67
0.71
3.13
0.21
4.44
Total Liabilities
503.71
350.35
226.06
198.66
187.49
158.94
129.95
109.76
120.26
Net Block
209.48
41.19
39.75
43.36
31.75
33.98
33.71
31.16
34.69
Gross Block
255.58
80.07
72.98
71.05
53.58
50.12
44.11
35.99
62.47
Accumulated Depreciation
46.10
38.88
33.22
27.69
21.83
16.14
10.40
4.83
27.78
Non Current Assets
243.80
166.06
82.32
50.63
55.88
40.91
39.12
45.78
48.64
Capital Work in Progress
24.94
99.01
25.65
0.44
12.16
1.06
0.00
0.00
0.00
Non Current Investment
0.00
0.00
0.00
0.00
1.31
1.36
0.00
0.55
0.50
Long Term Loans & Adv.
6.06
22.33
13.49
2.77
7.93
1.95
2.85
9.71
9.30
Other Non Current Assets
2.42
2.54
2.34
2.86
2.73
2.56
2.57
4.35
4.15
Current Assets
259.91
184.28
143.74
148.02
131.62
118.02
90.83
63.98
71.62
Current Investments
0.00
0.00
11.48
42.79
0.01
1.47
0.52
0.00
0.00
Inventories
61.47
37.84
20.76
22.43
28.82
22.52
14.43
15.27
14.12
Sundry Debtors
141.42
112.41
73.40
67.83
79.35
63.87
58.65
43.60
44.06
Cash & Bank
12.09
9.98
4.68
2.43
10.40
12.13
4.13
1.58
12.74
Other Current Assets
44.93
0.74
1.70
0.45
13.04
18.03
13.10
3.53
0.69
Short Term Loans & Adv.
43.84
23.31
31.71
12.09
12.59
17.52
12.57
0.20
0.12
Net Current Assets
69.53
64.49
102.20
104.40
65.74
57.51
33.94
21.20
15.44
Total Assets
503.71
350.34
226.06
198.65
187.50
158.93
129.95
109.76
120.26

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
-4.71
21.66
-1.07
24.45
14.45
20.43
6.34
-2.11
0.00
PBT
18.72
23.55
27.88
27.12
32.80
34.59
12.79
7.48
0.00
Adjustment
15.33
8.81
4.85
10.37
6.23
6.63
6.27
5.88
0.00
Changes in Working Capital
-29.29
-1.90
-28.13
-6.37
-14.53
-10.36
-10.17
-13.88
0.00
Cash after chg. in Working capital
4.76
30.46
4.60
31.12
24.50
30.87
8.89
-0.52
0.00
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-9.46
-8.79
-5.67
-6.68
-10.04
-10.44
-2.56
-1.59
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-104.78
-77.82
-6.63
-43.37
-12.60
-9.35
-8.07
-1.53
0.00
Net Fixed Assets
-7.78
-0.52
-2.55
-5.31
-14.56
-7.07
-8.12
26.48
Net Investments
-10.21
-22.10
25.52
-40.25
1.51
-2.31
0.03
-0.30
Others
-86.79
-55.20
-29.60
2.19
0.45
0.03
0.02
-27.71
Cash from Financing Activity
110.43
60.60
9.42
10.50
-2.82
-3.89
4.04
-7.52
0.00
Net Cash Inflow / Outflow
0.94
4.44
1.72
-8.43
-0.96
7.18
2.30
-11.16
0.00
Opening Cash & Equivalents
7.84
3.40
1.68
10.10
11.07
3.88
1.58
12.74
0.00
Closing Cash & Equivalent
8.78
7.84
3.40
1.68
10.10
11.07
3.88
1.58
0.00

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
338.96
315.63
287.16
250.34
206.27
164.07
127.14
111.14
98.95
ROA
2.46%
5.45%
9.80%
10.52%
13.94%
14.71%
7.61%
5.99%
5.37%
ROE
5.54%
9.03%
13.46%
15.53%
22.76%
25.47%
13.35%
11.45%
11.38%
ROCE
7.76%
12.57%
17.18%
20.24%
30.83%
39.30%
18.10%
11.47%
14.23%
Fixed Asset Turnover
1.53
2.85
3.35
3.80
4.40
4.66
3.46
2.41
2.10
Receivable days
179.99
155.57
106.98
113.54
114.55
101.85
134.69
134.78
122.67
Inventory Days
70.42
49.06
32.72
39.53
41.06
30.72
39.13
45.19
39.31
Payable days
128.36
99.70
66.97
93.48
91.33
56.53
92.40
126.93
125.22
Cash Conversion Cycle
122.06
104.93
72.73
59.59
64.28
76.03
81.42
53.04
36.75
Total Debt/Equity
0.80
0.27
0.11
0.09
0.01
0.05
0.12
0.10
0.34
Interest Cover
5.60
10.07
22.35
36.44
38.93
40.77
14.60
9.26
7.29

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017

News Update:


  • Bharat Parenterals acquires additional stake in Innoxel
    25th Jun 2024, 11:42 AM

    This led to increase in its stake of BPL from 51 % to 55.89% in Innoxel

    Read More
  • Bharat Parenterals to acquire additional stake in Varenyam Biolifesciences
    6th Jun 2024, 11:10 AM

    The said acquisition is expected to be completed by June 30, 2024 subject to approval of shareholders

    Read More
  • Bharat Parenterals planning to acquire additional stake in Innoxel Lifesciences
    6th Jun 2024, 09:23 AM

    The said acquisition is expected to be completed by June 30, 2024 subject to approval of shareholders

    Read More
  • Bharat Parenterals - Quarterly Results
    22nd May 2024, 17:44 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.